14 Mar 2016 07:00
14 March 2016
Instem plc("Instem")
Notice of Results
Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, will announce full year results for the year ended 31 December 2015 on Tuesday 5 April 2016.
Management will be hosting a presentation for analysts on the day of the results at 10.30am at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD.
Analysts wishing to attend the presentation should register their interest by emailing instem@walbrookpr.com or by telephoning 020 7933 8780.
For further information, please contact:
Instem plc | Tel: +44 (0) 1785 825 600 |
Phil Reason, CEO | www.instem.com |
Nigel Goldsmith, CFO |
|
|
|
N+1 Singer (Nominated Adviser & Broker) | Tel: +44 (0) 20 7496 3000 |
Richard Lindley |
|
Nick Owen |
|
James White |
|
|
|
Walbrook PR Ltd | Tel: +44 (0) 20 7933 8780 or |
Paul Cornelius | instem@walbrookpr.com |
Sam Allen |
|
Helen Cresswell |
|
Paul Whittington |
|
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients from offices in the United States, the United Kingdom, India, China and Japan, with an additional presence in France.
To learn more about Instem solutions and its mission, please visit www.instem.com